Acarbose, insulin in Type 2 diabetes w/ non-alcoholic liver cirrhosis – (02-02-01)



Acarbose, insulin in Type 2 diabetes w/ non-alcoholic liver cirrhosis

This study examines the use of acarbose, an alpha-glucosidase inhibitor in patients whose liver does not function well. The results were good for control blood sugar levels. Whole grains also have alpha-glucosidase inhibitors present in them, which are processed out during refinement. We don’t need to spend a money on a study comparing whole grains and glucose control–several studies already confirm the benefits of whole grains on glycemic control.

Synergy Abstract

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Diabetes (Type 2)
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”